SCHEMBL6171064

SCHEMBL6171064

Cc1ncc(C)c(C(O)=S)n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483475 0.79 LMNA (0.34) —
SCHEMBL2171572 0.79 — —
SCHEMBL12858036 0.78 MEN1 (0.38) NTRK1
SCHEMBL11609269 0.76 — —
SCHEMBL15006470 0.72 DPP4 (0.39) NTRK1
SCHEMBL19118962 0.70 HPGD (0.39) NTRK1
SCHEMBL11528021 0.70 CYP1A2 (0.31) —
SCHEMBL22476599 0.69 NPSR1 (0.50) NTRK1
SCHEMBL13727933 0.68 GAA (0.40) NTRK1
SCHEMBL29184321 0.68 BAZ2B (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6914160-B1 Oxytocin inhibitors PFIZER INC (US) 2005-07-05 — — US disclosed
EP-1537085-A1 OXYTOCIN INHIBITORS Pfizer Limited (GB) 2005-06-08 — — EP disclosed
WO-2004020414-A1 OXYTOCIN INHIBITORS PFIZER LIMITED (GB) 2004-03-11 — — WO disclosed
Send feedback